Skip to main navigation

Main navigation

About Us
Commitments
Products
Partnerships
- Grants
- Partnerships for the Future
News
- In The News
- Archive
Events
Investors
Careers

Home
Investors
In the News
Archive
Events

Pacira in the News

Recent News

Pacira BioSciences Reports Second Quarter 2020 Financial Results and Business Update

08/06/20

Pacira BioSciences to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

08/05/20

Pacira Announces Publication of Phase 4 Study of EXPAREL in Cesarean Section Procedures in Anesthesia & Analgesia

08/05/20

Pacira BioSciences Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients

08/04/20

Pacira to Report Second Quarter 2020 Financial Results on Thursday August 6, 2020

07/30/20

Browse the press release archive

Shareholder Tools

Print Page
RSS Feeds
Email Alerts

Contact Us
Legal
Site Map
Privacy Notice

EXPAREL^® (bupivacaine liposome injectable suspension), the EXPAREL logo, iovera^o, the iovera^o logo, Pacira, and the Pacira logo are registered trademarks of Pacira BioSciences, Inc. All other trademarks referenced herein are the property of their respective owners.